Neurologix to Present at Roth Capital Partners 2010 OC Growth Stock Conference – MarketWatch (press release)
By admin
|
Neurologix to Present at Roth Capital Partners 2010 OC Growth Stock Conference
MarketWatch (press release) Neurologix, Inc. (OTC:NRGX) is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of life-altering gene … Media & Internet Companies Get Spotlight at ROTH Capital Partners 22nd Annual …PharmiWeb.com (press release) Pluristem to Present at the ROTH 22nd Annual OC Growth ConferenceCNNMoney.com (press release) |
March 9th, 2010
This author published 9263 posts in this site.Share
You must be logged in to send a comment.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research